Disciplined Investments’s Oncolytics Biotech ONCY Stock Holding History

Disciplined Investments’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,189	Closed	-$13.5K	–	1111
2023 Q2	$13.5K	Hold	5,189	–	–	0.01%	305
2023 Q1	$6.23K	Buy	+5,189	New	+$8.15K	﹤0.01%	399
2022 Q4	–	Sell	-5,189	Closed	-$6K	–	1674
2022 Q3	$6K	Hold	5,189	–	–	﹤0.01%	411
2022 Q2	$5K	Hold	5,189	–	–	﹤0.01%	449
2022 Q1	$8K	Hold	5,189	–	–	﹤0.01%	397
2021 Q4	$7K	Hold	5,189	–	–	﹤0.01%	374
2021 Q3	$11K	Hold	5,189	–	–	0.01%	303
2021 Q2	$14K	Hold	5,189	–	–	0.01%	285
2021 Q1	$20K	Buy	+5,189	New	+$15.5K	0.01%	231

Other funds holding ONCY

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Disciplined Investments's ONCY Position: Q3 2023 in Review

Disciplined Investments sold out of Oncolytics Biotech (ONCY) in Q3 2023, closing a stake of 5,189 shares — an estimated $13.5K sold.

Disciplined Investments first reported a position in ONCY in Q1 2021 and held it in 9 quarters. The position peaked at $20K in Q1 2021. 33 funds tracked by Wall St. Rank hold ONCY as of Q3 2023.

Disciplined Investments reported no remaining Oncolytics Biotech position as of Q3 2023 after selling out during the quarter.
Disciplined Investments sold 5,189 Oncolytics Biotech shares in Q3 2023, an estimated $13.5K.
Disciplined Investments first reported a position in Oncolytics Biotech in Q1 2021 and held it in 9 quarters.
Disciplined Investments's Oncolytics Biotech position peaked at $20K in Q1 2021.
33 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.